Skip to Main Content
Skip Nav Destination

Online Ahead of Print

e-Letters – Observations March 19 2025
Oral Glucagon-Like Peptide 1 Analog as an Adjuvant Therapy in Generalized Lipodystrophy
E-Letters – Observations March 18 2025
Modeling Cardiovascular Protection With SGLT Inhibition in Type 1 Diabetes: A Risk-Based Approach to Guide Therapy?
Original Article March 18 2025
Early Fasting Serum Glucose or Weight Reduction With Tirzepatide and Metabolic Outcomes in People With Type 2 Diabetes: A Post Hoc Analysis of the SURPASS Trials
E-Letters – Observations March 17 2025
Use of Medical Identification for People Living With Type 1 Diabetes: Results From the BETTER Registry
Brief Report March 17 2025
Progression of Cerebral Small Vessel Disease Among Neurologically Asymptomatic Middle-Aged Individuals With Type 1 Diabetes
Original Article March 12 2025
Quantifying Environmental Waste From Diabetes Devices in the U.S.
e-Letters – Observations March 10 2025
Effect of Oral Semaglutide Versus Comparators on Multiple Cardiometabolic Risk Factor Control in Adults With Type 2 Diabetes
Original Article March 10 2025
Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?
Original Article March 3 2025
One-Hour Oral Glucose Tolerance Test for the Postpartum Reclassification of Women With Hyperglycemia in Pregnancy
Original Article February 28 2025
Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of Heart Failure and Chronic Kidney Disease
Brief Report February 26 2025
Isolated Glucosuria in Adolescence and Early-Onset Diabetes: A Nationwide Cohort Study of 1.6 Million Adolescents
Original Article February 26 2025
Early Continuous Glucose Monitor Use in Children and Adolescents With Type 1 Diabetes: Rates of Initiation and Impact on Glycemic Outcomes
Original Article February 25 2025
Differential Treatment Effects on β-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
Original Article February 25 2025
Development and Validation of the Patient-Level Chinese Diabetes Outcome Model on Long-term Complications in Type 2 Diabetes: An Application of the Hong Kong Diabetes Register
Original Article February 18 2025
Association of Diabetic Ketoacidosis at Onset, Diabetes Technology Uptake, and Clinical Outcomes After 1 and 2 Years of Follow-up: A Collaborative Analysis of Pediatric Registries Involving 9,269 Children With Type 1 Diabetes From Nine Countries
Original Article February 18 2025
Alcohol Intake, Drinking Pattern, and Risk of Type 2 Diabetes in Three Prospective Cohorts of U.S. Women and Men
e-Letters: Observations February 14 2025
Flying With Type 1 Diabetes as Commercial Airline Pilots in the U.S.: The Sky Is the Limit for People With Type 1 Diabetes
Original Article February 14 2025
Longitudinal Determination of Diabetes Complications and Other Clinical Variables as Risk Factors for Diabetic Ketoacidosis in Type 1 Diabetes
Original Article February 14 2025
Association Between Self-Monitored Blood Glucose and Continuous Glucose Monitoring in Youth With Type 1 Diabetes and Medicaid Insurance
Original Article February 14 2025
Arterial Stiffness Is Related to Diabetes-Associated Microvascular Complications: The SEARCH for Diabetes in Youth Study
Perspectives in Care February 14 2025
The Glycemic Impact of Protein Ingestion in People With Type 1 Diabetes
Original Article February 14 2025
Islet Transplantation Versus Standard of Care for Type 1 Diabetes Complicated by Severe Hypoglycemia From the Collaborative Islet Transplant Registry and the T1D Exchange Registry
Original Article February 12 2025
Association of Historical Redlining With Gestational Diabetes Mellitus: The Mediating Role of BMI and Area Deprivation Index
Original Article February 11 2025
Understanding the Impact of Diabetic Peripheral Neuropathy and Neuropathic Pain on Quality of Life and Mental Health in 6,960 People With Diabetes
Original Article February 11 2025
Sex-Specific Blood Pressure Trajectories and Cardiovascular Disease in Type 1 Diabetes: 32-Year Follow-up of the Pittsburgh Epidemiology of Diabetes Complications Cohort
Original Article February 11 2025
Lung Function Impairment and Risks of Incident Cardiovascular Diseases and Mortality Among People With Type 2 Diabetes: A Prospective Cohort Study
Original Article February 10 2025
The Burden of Diabetes Mortality by County, Race, and Ethnicity in the U.S., 2000–2019
Original Article February 6 2025
Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial
Original Article February 4 2025
Health-Related Quality of Life and Health Utility After Metabolic/Bariatric Surgery Versus Medical/Lifestyle Intervention in Individuals With Type 2 Diabetes and Obesity: The ARMMS-T2D Study
Original Article February 4 2025
Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis
Original Article February 3 2025
Short-Term Metformin Protects Against Glucocorticoid-Induced Toxicity in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial
e-Letters: Observations January 31 2025
Wave in Pediatric Type 1 Diabetes Incidence After the Emergence of COVID-19: Peak and Trough Patterns in German Youth—A Population-Based Study From the Prospective Multicenter DPV Registry
Original Article January 31 2025
Screening for Metabolic Dysfunction–Associated Steatotic Liver Disease–Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study
Original Article January 31 2025
In-Hospital Diabetes Management by a Diabetes Team and Insulin Titration Algorithms Based on Continuous Glucose Monitoring or Point-of-Care Glucose Testing in Patients With Type 2 Diabetes (DIATEC): A Randomized Controlled Trial
e-Letters – Observations January 29 2025
New Therapeutic Perspectives in Type B Insulin Resistance Syndrome: Efficacy of a Multitarget Therapy With Obinutuzumab and Mycophenolate Mofetil in Two Patients With Insulin Receptor Autoantibodies and Systemic Lupus Erythematosus
Original Article January 29 2025
Islet Autoantibody Screening Throughout Australia Using In-Home Blood Spot Sampling: 2-Year Outcomes of Type1Screen
Brief Report January 28 2025
Longitudinal Associations of PFAS Exposure With Insulin Sensitivity and β-Cell Function Among Hispanic Women With Gestational Diabetes Mellitus History
Original Article January 24 2025
Diabetes Risk After Treatment for Childhood and Young Adult Cancer
Erratum January 23 2025
Erratum. 7. Diabetes Technology: Standards of Care in Diabetes—2025. Diabetes Care 2025;48(Suppl. 1):S146–S166
Erratum January 23 2025
Erratum. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2025. Diabetes Care 2025;48(Suppl. 1):S86–S127
e-Letters: Observations January 22 2025
An Atypical Presentation of Cytokine Release Syndrome With Signs of Arthritis During Treatment With Teplizumab in a Pediatric Patient
e-Letters: Observations January 22 2025
Value-Based Pricing and Its Implications for the Newly Announced Medicare Negotiated Price Under the Inflation Reduction Act
Original Article January 17 2025
Derivation and Validation of D-RISK: An Electronic Health Record–Driven Risk Score to Detect Undiagnosed Dysglycemia in Clinical Practice
Original Article November 20 2024
Cost-Effectiveness of the National Diabetes Prevention Program: A Real-World, 2-Year Prospective Study
Original Article October 3 2024
Metformin Use and Risk of Delirium in Older Adults With Type 2 Diabetes
Original Article September 26 2024
Continuous Glucose Monitoring With Geriatric Principles in Older Adults With Type 1 Diabetes and Hypoglycemia: A Randomized ControlledTrial
Original Article August 9 2024
Economic Costs Attributed to Diagnosed Diabetes in Each U.S. State and the District of Columbia: 2021
Close Modal

or Create an Account

Close Modal
Close Modal